Andrew Hyland, Ph.D.

Dr. Hyland, Roswell Park Cancer Institute, is the scientific lead investigator for the landmark Population Assessment of Tobacco and Health (PATH) Study, a joint FDA/NIH research project which is supported by CTP through a National Institute on Drug Abuse research contract. The study will help scientists learn how and why people start using tobacco, switch from one tobacco product to another, quit using it, and start using it again after they’ve quit. 

The opinions in these videos reflect the views of individual researchers, and not necessarily the official position of the FDA’s Center for Tobacco Products. These videos represent accurate information about the design of these CTP supported studies at the time the interviews were conducted (Spring 2014).

• Read the abstract of the PATH Study.
• View more Tobacco Regulatory Science In Action videos